Mary Foley

Dalhousie University - Department of Microbiology & Immunology

SCHOLARLY PAPERS

1

DOWNLOADS

110

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immunogenicity of a SARS-CoV-2 DNA Vaccine Formulated With the Fusion-Associated Small Transmembrane Protein Proteolipid Vehicle Delivery System

Number of pages: 49 Posted: 01 Nov 2022
Arun Raturi, Jailal Ablack, Ping Wee, Prakash Bhandari, Douglas W. Brown, Maryam Hejazi, Nichole McMullen, Liliya Grin, Hector Vega, Henry Garcia, Natasha Govindasamy, Jitendra Kumar, Paola Solis Ares, Chandra McAllister, Katia Carmine-Simmen, Perrin H. Beatty, Adam Nelson, Eric S. Pringle, Thornton Thompson, Manoj Parmar, Jennifer Gyoba, Hong Jiang, Brent Johnston, Craig McCormick, Mary Foley, Magen Ellen Francis, Brian Abel, Alyson Kelvin, Roy Duncan and John D. Lewis
Entos Pharmaceuticals, OncoSenX, Entos Pharmaceuticals, Entos Pharmaceuticals, University of Alberta - Department of Oncology, University of Alberta - Department of Oncology, Dalhousie University - Department of Microbiology & Immunology, Entos Pharmaceuticals, Entos Pharmaceuticals, Oisin Biotechnologies, Entos Pharmaceuticals, Entos Pharmaceuticals, Entos Pharmaceuticals, Entos Pharmaceuticals, University of Alberta - Department of Oncology, Entos Pharmaceuticals, Dalhousie University - Department of Microbiology & Immunology, Dalhousie University - Department of Microbiology & Immunology, Aegis Life, Entos Pharmaceuticals, Entos Pharmaceuticals, Aegis Life, Dalhousie University - Department of Microbiology & Immunology, Dalhousie University - Department of Microbiology & Immunology, Dalhousie University - Department of Microbiology & Immunology, University of Saskatchewan - Vaccine and Infectious Disease Organization, Aegis Life, University of Saskatchewan - Vaccine and Infectious Disease Organization, Dalhousie University - Department of Microbiology & Immunology and University of Alberta - Department of Oncology
Downloads 110 (540,642)

Abstract:

Loading...

CD8+ T cells, cytotoxic T lymphocytes, FAST protein, genetic adjuvants, neutralizing antibodies, plasmid DNA vaccine, proteolipid vehicle, PLV, SARS-CoV-2, Spike protein